Business Analysis Archives

The Silent Failure of Shadow IT: Why User Adoption Is Your Biggest Regulatory Risk

Sep 9, 2026 | Business Analysis, Change Management, Training

When new systems don’t fit real workflows, employees quietly fall back on shadow IT – and in GxP environments, that creates serious regulatory exposure. Closing the gap between system validation and true user adoption is one of the highest-leverage investments a life sciences organization can make.

Why Business Analysts are Needed in Biopharma

May 5, 2026 | Business Analysis

The biopharma and life sciences industries are currently undergoing a massive digital transformation. We are seeing unprecedented investments in R&D informatics…

The Radical Art of Business Analysis

Jul 7, 2020 | Business Analysis

With the pace of digital transformation rapidly increasing available data on all aspects of life in our world, data-driven organizations are being forced to make critical adjustments in their data management strategies in order to remain competitive. Industry-leading...

The Silent Failure of Shadow IT: Why User Adoption Is Your Biggest Regulatory Risk

Why Business Analysts are Needed in Biopharma

The Radical Art of Business Analysis

Recent Posts

The Silent Failure of Shadow IT: Why User Adoption Is Your Biggest Regulatory Risk

Accelerating Validation in Biopharma: How AI Transforms ELN Compliance and PQ Execution

Key Takeaways from PHUSE: Building and Validating a Trustworthy RWD Analytics Platform

Data Science and Cybersecurity in the Modern Lab: Protecting R&D Pipelines in a Digitized Era

Why Business Analysts are Needed in Biopharma

Categories